193 related articles for article (PubMed ID: 14599083)
1. Irinotecan (Campto) in the treatment of pancreatic cancer.
Pizzolato JF; Saltz LB
Expert Rev Anticancer Ther; 2003 Oct; 3(5):587-93. PubMed ID: 14599083
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan in the management of patients with pancreatic cancer.
Green MR; Harper M; Safa A; Sherman CA; Mushtaq CM; Bahadori H; Brescia FJ; Rocha Lima CM
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):31-3. PubMed ID: 11200146
[TBL] [Abstract][Full Text] [Related]
3. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
[TBL] [Abstract][Full Text] [Related]
4. Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practice.
Cunningham D
Semin Oncol; 1999 Feb; 26(1 Suppl 5):1-5. PubMed ID: 10213008
[TBL] [Abstract][Full Text] [Related]
5. New agents in gastrointestinal malignancies: Part 1: Irinotecan in clinical practice.
Stucky-Marshall L
Cancer Nurs; 1999 Jun; 22(3):212-9. PubMed ID: 10376382
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan(Campto R): efficacy as third/forth line therapy in advanced pancreatic cancer.
Klapdor R; Fenner C
Anticancer Res; 2000; 20(6D):5209-12. PubMed ID: 11326696
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan.
Ko AH
Int J Nanomedicine; 2016; 11():1225-35. PubMed ID: 27099488
[TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of irinotecan in solid tumours.
Siu LL; Rowinsky EK
Drug Saf; 1998 Jun; 18(6):395-417. PubMed ID: 9638386
[TBL] [Abstract][Full Text] [Related]
9. CPT-11. The European experience.
Armand JP; Terret C; Couteau C; Rixe O
Ann N Y Acad Sci; 1996 Dec; 803():282-91. PubMed ID: 8993522
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan: toward clinical end points in drug development.
Pazdur R
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):13-21. PubMed ID: 9726086
[TBL] [Abstract][Full Text] [Related]
11. [Clinical activity spectrum of irinotecan].
Cottu PH; Extra JM; Lerebours F; Espie M; Marty M
Bull Cancer; 1998 Dec; Spec No():21-5. PubMed ID: 9932080
[TBL] [Abstract][Full Text] [Related]
12. [Irinotecan chemotherapy for patients with advanced or relapsed pancreatic neoplasm].
Sekikawa T; Akaike A; Ushio J; Sato A; Matsukawa M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():203-6. PubMed ID: 16457250
[No Abstract] [Full Text] [Related]
13. Irinotecan in the first-line treatment of colorectal cancer.
Saltz LB
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):54-8. PubMed ID: 9726092
[TBL] [Abstract][Full Text] [Related]
14. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
Mitry E; Ducreux M; Rougier P
Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
[TBL] [Abstract][Full Text] [Related]
15. [CPT-11: new drug for metastatic colorectal cancer].
Barone C; Pozzo C; Cassano A
Tumori; 1999; 85(6):A1-11. PubMed ID: 10774581
[No Abstract] [Full Text] [Related]
16. CPT-11: the European clinical development.
Terret C; Couteau C; Armand JP
J Infus Chemother; 1996; 6(3):152-7. PubMed ID: 9229329
[TBL] [Abstract][Full Text] [Related]
17. The emerging world role of irinotecan in lung cancer.
Langer CJ
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan.
Saijo N
Ann N Y Acad Sci; 1996 Dec; 803():292-305. PubMed ID: 8993523
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.
Yi SY; Park YS; Kim HS; Jun HJ; Kim KH; Chang MH; Park MJ; Uhm JE; Lee J; Park SH; Park JO; Lee JK; Lee KT; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2009 May; 63(6):1141-5. PubMed ID: 18839175
[TBL] [Abstract][Full Text] [Related]
20. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
